Following on from the recent sell-out Superbugs & Superdrugs European show, SMi Training are delighted to announce the return of the popular anti-microbial resistance (AMR) workshop taking place in central London on Monday 11th July 2016, “Changing the Paradigm in the Development and use of Antimicrobials”.
Hosted by Conrad Lichtenstein, Founder and Chief Scientific Officer from Nemesis Bioscience Ltd; and Neil Woodford, Head of the Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit at Public Health England, the interactive training workshop will address key questions surrounding AMR, such as:
• How can funding strategies encourage investment?
• What are the alternative approaches to antimicrobial drug development - peptides, phage therapy, immunotherapy, microbiome engineering?
• How can regulatory initiatives improve new drug development?
• How can epidemiological studies and genome sequencing optimise the use of current antimicrobials?
Previous attendees at SMi's workshops on AMR include:
ABAC Therapeutics, Absynth Biologics, Achaogen, Actelion, Atlas Genetics, BIOASTER, Brandenburg Antiinfektiva GmbH and Forschungszentrum Borstel, Emergent Biosolutions, Evotec, MHRA, Propharma Partners Ltd, Roche, Syner-Med Ltd, TranScrip Partners, Vifor (International) Ltd, Voyage tour.
Details are available at: www.smi-online.co.uk/goto/2016antimicrobial-resistance.asp
Venue:
To Be AnnouncedOrganiser Contact Details:
SMi GroupT:
+442078276000tarri@smi-online.co.uk
